Nitric Oxide-Dependent Neovascularization Role in the Lower Extremity Disease

Author(s): Monica G. Arellano Mendoza, Hilda Vargas Robles, Eunice Romo, Amelia Rios, Bruno Escalante

Journal Name: Current Pharmaceutical Design

Volume 13 , Issue 35 , 2007

Become EABM
Become Reviewer
Call for Editor


Peripheral arterial occlusive disease (PAD) describes vascular disorders associated with ischemia and PAD affects about 8 million people in the United States. Moreover, PADs prevalence can increase dramatically if cardiovascular disease is present. In healthy individuals reducing blood flow through the lower extremity is followed by a physiological process to limit ischemia in the distal tissue. This process is called revascularization and impairing revascularization results in PAD. Studies suggest nitric oxide (NO) maybe involved in the ischemia-dependent hindlimb revascularization process. NO is increased in the ischemic hindlimb and eliminating NO impairs the revascularization process. Moreover, restoring NO improves hindlimb revascularization. NO may be acting through its effects on vascular tone, cell migration, or extracellular matrix degradation. The present review illustrates nitric oxides critical role in the ischemia-induced hindlimb revascularization. Thus, restoring normal NO levels in diseased arteries may represent a viable therapeutic avenue by supplementing exogenous NO or employing therapeutic strategies to either increase NO synthesis and its messengers or decrease NO catabolism.

Keywords: Angiogenesis, arteriogenesis, nitric oxide, revasculatization, peripheral arterial disease

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2007
Page: [3591 - 3596]
Pages: 6
DOI: 10.2174/138161207782794103
Price: $65

Article Metrics

PDF: 2